Neuraxis, INC Income Statement
NRXS|3 years of annual SEC 10-K data (FY2023-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 3 fiscal years. All figures from audited SEC 10-K filings.
Neuraxis, INC reported $4M in revenue and $8M in net loss for FY2025. Revenue has grown at a 15.3% compound annual rate over the past 2 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -10.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $3.6M | $2.5M | $2.7M |
| Cost of Revenue | $562.9K | $303.3K | $297.1K |
| Gross Profit | $3.0M | $2.2M | $2.4M |
| SG&A Expense | $8.1M | $8.3M | $5.1M |
| R&D Expense | $493.6K | $169.3K | $225.6K |
| Operating Income | -$7.8M | -$6.7M | -$3.4M |
| Interest Expense | $74.0K | $476.4K | $318.7K |
| Net Income | -$7.8M | -$14.6M | -$4.8M |
| EPS (Basic) | -$1.22 | -$4.50 | -$2.77 |
| EPS (Diluted) | -$1.22 | -$4.50 | -$2.77 |
| Shares Outstanding | 7.0M | 6.5M | 2.0M |
| Gross Margin | 84.2% | 87.7% | 88.9% |
| Operating Margin | -219.4% | -270.9% | -125.6% |
| Profit Margin | -218.6% | -594.6% | -178.1% |